Microbiome Modulation as a Novel Strategy to Treat and Prevent Respiratory Infections

Acute and chronic lower airway disease still represent a major cause of morbidity and mortality on a global scale. With the steady rise of multidrug-resistant respiratory pathogens, such as Pseudomonas aeruginosa and Klebsiella pneumoniae, we are rapidly approaching the advent of a post-antibiotic e...

Descripción completa

Detalles Bibliográficos
Autores principales: Mindt, Barbara C., DiGiandomenico, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029693/
https://www.ncbi.nlm.nih.gov/pubmed/35453224
http://dx.doi.org/10.3390/antibiotics11040474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029693/
https://www.ncbi.nlm.nih.gov/pubmed/35453224
http://dx.doi.org/10.3390/antibiotics11040474

Ejemplares similares